Bayer secured $3.4B in equity from ‌Apollo-managed funds in deal tied to long-acting reversible contraceptives, or LARC, business, ​aiming to bolster its capital ​structure while preserving control

https://www.reuters.com/legal/litigation/bayer-gets-3-billion-apollo-deal-contraceptives-unit-2026-07-10/